Loading clinical trials...

A RCT of Moist Ag Dressing in Chronic Wound | Clinical Trials | Clareo Health

NOT_YET_RECRUITINGNA

A RCT of Moist Ag Dressing in Chronic Wound

Dry Versus Moist Ag Dressings for Local Wound Infections: A Randomized Controlled Trial on Effectiveness and Cost-Effectiveness

NCT07235254•Peking University Third Hospital

View on ClinicalTrials.gov

Summary

This study aims to explore the differences in efficacy and cost-effectiveness between self-adhesive soft polysilicone silver ion foam dressings and traditional silver dressings in local infected wounds through a prospective randomized controlled study. The goal is to provide evidence-based medical support for clinical application, further shorten the wound healing time, and reduce the economic burden on the medical system and patients.

Eligibility

Age

18 - 80 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•1. The patient's age ranges from 18 to 80 years old.
•2. According to the IWII wound infection staging, infected wounds are classified as local infections\*.
•3. The wound type is ulcer, with an ulcer area ranging from 1 to 40 cm².
•4. The wound stage is in the necrosis stabilization phase, granulation growth phase, or epithelial crawling phase\*\*.
•5. Voluntary participation in this study and signing the informed consent form

Exclusion Criteria

•1. Severe diseases such as acute myocardial infarction, heart failure, hepatitis, shock, and respiratory failure have not been corrected yet;
•2. The blood sugar level of diabetes is out of control, with fasting blood sugar \> 15 mmol/L and glycosylated hemoglobin ≥ 10%;
•3. There is active bleeding in the wound, and the conventional basic treatment plan cannot be implemented;
•4. Serum albumin \< 20 g/L; hemoglobin \< 60 g/L; platelets \< 50 × 109/L;
•5. Disseminated infection or systemic infection state, and antibiotics are being used or will be used for treatment;
•6. Patients with advanced malignant tumors;
•7. The patient is in the active stage of autoimmune diseases;
•8. The patient has previously been allergic to self-adhesive soft polysilicone silver ion foam dressings (Meipikang Silver) or Anxidean Nano Silver Trauma Patch;
•9. The patient cannot cooperate or has a mental disorder;
•10. According to the investigator's judgment, the subject has clear reasons that affect wound healing and is not suitable for this study or cannot comply with the requirements of this study.

Locations (1)

Peking University Third Hospital

Beijing, Beijing Municipality, China

Key Dates

Start Date

December 1, 2025

Primary Completion Date

July 1, 2026

Completion Date

September 1, 2027

Last Updated

November 19, 2025

Enrollment

ESTIMATED participants

Conditions

Chronic WoundHard to Heal WoundsDressingWound he'a'LingWound Healing

Interventions

Ag foam dressing named MepilexAg

DEVICE

Dry Ag dressing

DEVICE

Contacts

Long Zhang Executive Deputy Director, Medical Doctor

CONTACT

+86 010-82266699 longzh2000@163.com

Evaluation of ELU42 Topical Spray for the Treatment of Diabetic Foot Ulcers

NCT07396376

Diabetic Foot UlcerWagner Grade 1 - 2+2 more

View study

RECRUITINGNA

HealiAid Collagen Wound Dressing in Patients Undergoing Breast Tumor Surgery

NCT07209020

Breast TumorsWound Healing+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 19, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

A RCT of Moist Ag Dressing in Chronic Wound

Inclusion Criteria

Exclusion Criteria

Evaluation of ELU42 Topical Spray for the Treatment of Diabetic Foot Ulcers

HealiAid Collagen Wound Dressing in Patients Undergoing Breast Tumor Surgery

Evaluate Use of Tropocells(R) Autologous Platelet-rich Fibrin (PRF) for Wagner Grade 1 and Grade 2, Mild to Mod Neuroischemic Plantar Diabetic Foot Ulcer Wound Care.

Study of Biomarkers in Diabetic Chronic Wounds

Transcutaneous Application of Gaseous CO2

Evaluation of the Efficacy of Hyalomatrix® in the Healing of Chronic Venous Leg Ulcers